Seojin Kim
Junior Specialist
I am interested in how new treatments can disrupt mechanisms of GBM immunosuppression, particularly those involving tumor associated macrophages. I am also excited to explore PP2AC as a potential therapeutic target. In my free time I enjoy reading and baking.